News

The 540,000 sq ft building is leased until ... and others such as Barclays and Morgan Stanley give up surplus blocks. Canary Wharf Group, owned by QIA and Brookfield, has invested in adding ...
Financial giants from Barclays ... Canary Wharf took off and gained its new name. First came the revolutionary (at the time) automated train line, the DLR, and then came Britain's tallest building ...
LONDON, Oct 2 (Reuters) - London's Canary Wharf financial district wants to ... the area's office tenants - which include JP Morgan and Barclays - were supportive of the idea.
Building understands the practice behind the Heron Tower ... Other financial firms to have recently committed to remaining in Canary Wharf include Barclays, which is staying until 2039, and Morgan ...
LONDON, Dec 21 (Reuters) - Barclays BARC.L has signed an agreement with Canary Wharf Group (CWG ... tenure at the flagship One Churchill Place building by five years. The move comes as a ...
LONDON (Reuters) - Barclays (LON:BARC) has signed an agreement with Canary Wharf Group (CWG) to extend the lease on ... said it will extend its tenure at the flagship One Churchill Place building by ...
Barclays' decision to extend its stay in Canary Wharf also comes amid a wider review ... (Alliance News) - Nationwide Building Society and First Direct have both confirmed issues with their ...
Barclays Plc has agreed a ... a five-year extension to its lease at its Canary Wharf headquarters One Churchill Place, committing it to the building until 2039.
Canary Wharf Group said the bank had agreed a five year lease extension on its tower One Churchill Place. Barclays has also agreed to give back a second building at 5 North Colonnade which it ...
Canary Wharf Group said the bank had agreed a five year lease extension on its tower One Churchill Place. Barclays has also agreed to give back a second building at 5 North Colonnade which it decided ...
Canary Wharf Group has struck a pair of deals with Barclays, extending the lease on one building occupied by the bank and taking back another for potential conversion to life sciences space.